Predictive quality of census-based socio-economic indicators on Covid-19 infection risk at a fine spatial scale in France.

Publication date: Jul 01, 2025

The COVID-19 pandemic in France induced the development of a national, high spatiotemporal resolution confirmed infection cases database. We aimed to estimate the predictive ability of census-based indicators on the infection risk to assess their potential usefulness in future pandemic response. We collected and aggregated all counts of biologically confirmed cases of SARS-CoV-2 infection in the Auvergne-RhcF4ne-Alpes region in France at small-area statistical units between May 2020 and February 2021 (second wave). Ten census-based ecological covariates were evaluated as predictors of case incidence using a Poisson regression with conditional autoregressive (CAR) spatial effects. Benefits of CAR effects and covariates on model predictive ability was assessed comparing posterior predictive distribution of case incidence with the observed value for each statistical unit. Among 7,917,997 inhabitants, 438,992 infection cases over 5410 neighbourhoods were analysed. Spatial correlation was high for the periods before and after the epidemic peak, and illustrated with cartography. The addition of covariates to the null model led to an increase in satisfying prediction of + 5% from 14%, with a maximum of 21% across all periods. The ecological covariates assessed were insufficient to provide a satisfying prediction of infection risk without explicitly accounting for the spatial organization of the epidemic.

Open Access PDF

Concepts Keywords
Ecological Censuses
February COVID-19
France Emerging diseases
Pandemic Epidemiology
France
Humans
Incidence
Male
Modelling
Pandemics
Risk Factors
SARS-CoV-2
SARS-CoV-2
Socioeconomic Factors
Spatial statistics

Semantics

Type Source Name
disease IDO quality
disease MESH Covid-19
disease MESH infection
pathway REACTOME SARS-CoV-2 Infection
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Coenzyme M
drug DRUGBANK Aspartame
disease IDO process
disease MESH infectious disease
pathway REACTOME Infectious disease
drug DRUGBANK Huperzine B
disease MESH emerging infectious diseases
disease IDO susceptibility
drug DRUGBANK L-Citrulline
pathway REACTOME Reproduction

Original Article

(Visited 3 times, 1 visits today)